Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.

Screening and prostate-cancer mortality in a randomized European study.

Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M, Denis LJ, Recker F, Berenguer A, Määttänen L, Bangma CH, Aus G, Villers A, Rebillard X, van der Kwast T, Blijenberg BG, Moss SM, de Koning HJ, Auvinen A; ERSPC Investigators.

N Engl J Med. 2009 Mar 26;360(13):1320-8. doi: 10.1056/NEJMoa0810084. Epub 2009 Mar 18.

2.

Mortality results from a randomized prostate-cancer screening trial.

Andriole GL, Crawford ED, Grubb RL 3rd, Buys SS, Chia D, Church TR, Fouad MN, Gelmann EP, Kvale PA, Reding DJ, Weissfeld JL, Yokochi LA, O'Brien B, Clapp JD, Rathmell JM, Riley TL, Hayes RB, Kramer BS, Izmirlian G, Miller AB, Pinsky PF, Prorok PC, Gohagan JK, Berg CD; PLCO Project Team.

N Engl J Med. 2009 Mar 26;360(13):1310-9. doi: 10.1056/NEJMoa0810696. Epub 2009 Mar 18. Erratum in: N Engl J Med. 2009 Apr 23;360(17):1797.

3.

Mendelian randomisation and causal inference in observational epidemiology.

Sheehan NA, Didelez V, Burton PR, Tobin MD.

PLoS Med. 2008 Aug 26;5(8):e177. doi: 10.1371/journal.pmed.0050177. No abstract available.

4.

Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update.

Hewitson P, Glasziou P, Watson E, Towler B, Irwig L.

Am J Gastroenterol. 2008 Jun;103(6):1541-9. doi: 10.1111/j.1572-0241.2008.01875.x. Epub 2008 May 13. Review.

PMID:
18479499
5.

Aprotinin during coronary-artery bypass grafting and risk of death.

Schneeweiss S, Seeger JD, Landon J, Walker AM.

N Engl J Med. 2008 Feb 21;358(8):771-83. doi: 10.1056/NEJMoa0707571.

6.

Estimating effects from randomized trials with discontinuations: the need for intent-to-treat design and G-estimation.

Greenland S, Lanes S, Jara M.

Clin Trials. 2008;5(1):5-13. doi: 10.1177/1740774507087703.

PMID:
18283074
7.
8.

Surgical versus nonsurgical treatment for lumbar degenerative spondylolisthesis.

Weinstein JN, Lurie JD, Tosteson TD, Hanscom B, Tosteson AN, Blood EA, Birkmeyer NJ, Hilibrand AS, Herkowitz H, Cammisa FP, Albert TJ, Emery SE, Lenke LG, Abdu WA, Longley M, Errico TJ, Hu SS.

N Engl J Med. 2007 May 31;356(22):2257-70.

9.

Risk of death associated with the use of conventional versus atypical antipsychotic drugs among elderly patients.

Schneeweiss S, Setoguchi S, Brookhart A, Dormuth C, Wang PS.

CMAJ. 2007 Feb 27;176(5):627-32. Erratum in: CMAJ. 2007 May 22;176(11):1613.

10.

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.

Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Yates JC, Vestbo J; TORCH investigators.

N Engl J Med. 2007 Feb 22;356(8):775-89.

11.

Estimating the effect of smoking cessation on weight gain: an instrumental variable approach.

Eisenberg D, Quinn BC.

Health Serv Res. 2006 Dec;41(6):2255-66. Review.

12.

Instrumental variables and interactions in the causal analysis of a complex clinical trial.

Bond SJ, White IR, Sarah Walker A.

Stat Med. 2007 Mar 30;26(7):1473-96.

PMID:
16900567
14.

Drug copayment and adherence in chronic heart failure: effect on cost and outcomes.

Cole JA, Norman H, Weatherby LB, Walker AM.

Pharmacotherapy. 2006 Aug;26(8):1157-64.

PMID:
16863491
15.

A meta-analysis of the association between adherence to drug therapy and mortality.

Simpson SH, Eurich DT, Majumdar SR, Padwal RS, Tsuyuki RT, Varney J, Johnson JA.

BMJ. 2006 Jul 1;333(7557):15. Epub 2006 Jun 21. Review.

16.

A new preference-based analysis for randomized trials can estimate treatment acceptability and effect in compliant patients.

Walter SD, Guyatt G, Montori VM, Cook R, Prasad K.

J Clin Epidemiol. 2006 Jul;59(7):685-96. Epub 2006 Mar 27. Erratum in: J Clin Epidemiol. 2007 Nov;60(11):1203.

PMID:
16765271
17.

Calcium plus vitamin D supplementation and the risk of fractures.

Jackson RD, LaCroix AZ, Gass M, Wallace RB, Robbins J, Lewis CE, Bassford T, Beresford SA, Black HR, Blanchette P, Bonds DE, Brunner RL, Brzyski RG, Caan B, Cauley JA, Chlebowski RT, Cummings SR, Granek I, Hays J, Heiss G, Hendrix SL, Howard BV, Hsia J, Hubbell FA, Johnson KC, Judd H, Kotchen JM, Kuller LH, Langer RD, Lasser NL, Limacher MC, Ludlam S, Manson JE, Margolis KL, McGowan J, Ockene JK, O'Sullivan MJ, Phillips L, Prentice RL, Sarto GE, Stefanick ML, Van Horn L, Wactawski-Wende J, Whitlock E, Anderson GL, Assaf AR, Barad D; Women's Health Initiative Investigators.

N Engl J Med. 2006 Feb 16;354(7):669-83. Erratum in: N Engl J Med. 2006 Mar 9;354(10):1102.

18.

Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial.

Granger BB, Swedberg K, Ekman I, Granger CB, Olofsson B, McMurray JJ, Yusuf S, Michelson EL, Pfeffer MA; CHARM investigators.

Lancet. 2005 Dec 10;366(9502):2005-11.

PMID:
16338449
19.
20.

Analyzing a randomized trial on breast self-examination with noncompliance and missing outcomes.

Mealli F, Imbens GW, Ferro S, Biggeri A.

Biostatistics. 2004 Apr;5(2):207-22.

PMID:
15054026

Supplemental Content

Support Center